FDA Alerts

Sibutramine, Phenolphthalein Found in Weight Loss Product
The Food and Drug Administration (FDA) is advising consumers not to purchase or use Evolve Bee Pollen, a product promoted and sold for weight loss on www.beeextremelyamazed.com and on www.beefitamy.com .
Fecal Continence Restoration System Approved
The U.S. Food and Drug Administration today approved the Fenix Continence Restoration System to treat fecal incontinence in patients who are not candidates for, or have previously failed, medical or other surgical options.
FDA Proposes Tanning Bed Ban for Underage Kids
Today, the U.S. Food and Drug Administration announced important proposed steps ‎to protect public health by preventing the use of sunlamp products (also commonly known as indoor tanning beds) by minors and reducing the risk of using these devices for adults.
Thirty Plus Supplement May Pose Health Risk
The Food and Drug Administration (FDA) is advising consumers not to purchase or use Thirty Plus, a product promoted and sold for weight loss on various websites, including www.getskinny.bigcartel.com , and in some retail stores.
FDA: Do Not Take Power Tiger-X
The Food and Drug Administration (FDA) is advising consumers not to purchase or use Power Tiger-X, a product promoted and sold for sexual enhancement on various websites, including www.everestwholesales.com , and in some retail stores.
New Wearable Defibrillator for Kids
The U.S. Food and Drug Administration today approved a new indication for the LifeVest wearable cardioverter defibrillator.
Basaglar Gets FDA Green Light
The U.S. Food and Drug Administration today approved Basaglar (insulin glargine injection), a long-acting human insulin analog to improve glycemic control in adult and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.
Rx to Reverse Neuromuscular Blocking Approved
The U.S. Food and Drug Administration today approved Bridion (sugammadex) injection to reverse the effects of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide, which are used during certain types of surgery in adults.
A New Option for ALK-Positive Lung Cancer
The U.S. Food and Drug Administration today approved Alecensa (alectinib) to treat people with advanced (metastatic) ALK-positive non-small cell lung cancer (NSCLC) whose disease has worsened after, or who could not tolerate treatment with, another therapy called Xalkori (crizotinib).
Chemo Overdose Rx Approved
The U.S. Food and Drug Administration today approved Vistogard (uridine triacetate) for the emergency treatment of adults and children who receive an overdose of the cancer treatment fluorouracil or capecitabine, or who develop certain severe or life-threatening toxicities within four days of receiving these cancer treatments.